- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01614418
Radiofrequency Ablation for Gastric Metaplasia and Dysplasia
Endoscopic Radiofrequency Ablation for Gastric Metaplasia and Dysplasia
Gastric intestinal metaplasia (IM) and dysplasia, also referred to as intra-epithelial neoplasia, are well recognized precursors of gastric cancer. Apart from endoscopic surveillance, there is no other intervention which predictably eradicates pre-cancerous gastric lesions.
Endoscopic radiofrequency ablative (RFA) therapy has been recently shown to be highly effective in eradicating both IM and dysplasia in patients with Barrett's esophagus. However, the potential role of RFA to remove gastric IM and dysplasia remains unknown. In this study, we determine the feasibility of using endoscopic RFA in treating early gastric neoplasia (metaplasia and dysplasia). Patients with gastric metaplasia and/or dysplasia will be treated with endoscopic RFA. The safety and effects of RFA will be determined.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Phase 2
- Phase 1
Contacts and Locations
Study Locations
-
-
-
Hong Kong, Hong Kong
- University of Hong Kong
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Histological confirmation of gastric IM or dysplasia.
- The lesion is no larger than 5 cm in diameter.
- Age ≥ 18 years.
- No previous endoscopic mucosal resection or submucosal dissection.
- No active H. pylori infection.
- Subject is able to tolerate endoscopy and sedation.
- Subject agrees to participate, fully understands content of the informed consent, and signs the informed consent form.
Exclusion Criteria:
- Gastric cancer (intra-mucosal cancer or worse).
- Prior gastric irradiation or surgery.
- Anti-platelet or anti-thrombotic medication use that cannot be stopped for 7 days before and after RFA.
- Gastric ulcers, fistulae and varices.
- History of alcohol and/or controlled substance dependency.
- Pregnancy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Endoscopic radiofrequency ablation
Endoscopic radiofrequency ablation using BARRX HALO90 catheter
|
Endoscopic radiofrequency ablation
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Histological clearance of dysplasia/metaplasia
Time Frame: 6 month
|
6 month
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of Participants with Adverse Events
Time Frame: up to 6 month
|
up to 6 month
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HKU_WKL_RFA1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intestinal Metaplasia
-
National University Hospital, SingaporeNational Medical Research Council (NMRC), SingaporeUnknownIntestinal Metaplasia | Intestinal DysplasiaSingapore
-
Shandong UniversityUnknownGastric Intestinal Metaplasia | Confocal Laser Endomicroscopy | Biopsy | Operative Link on Gastric Intestinal MetaplasiaChina
-
Shandong UniversityCompletedIntestinal MetaplasiaChina
-
Xijing Hospital of Digestive DiseasesCompleted
-
Shandong UniversityUnknownGastric Intestinal MetaplasiaChina
-
Shandong UniversityUnknownGastric Intestinal MetaplasiaChina
-
Shandong UniversityUnknownGastric Intestinal MetaplasiaChina
-
Shandong UniversityCompletedGastric Intestinal MetaplasiaChina
-
Shandong UniversityUnknownGastric Intestinal MetaplasiaChina
-
King Chulalongkorn Memorial HospitalCompletedGastric Intestinal MetaplasiaThailand
Clinical Trials on Endoscopic radiofrequency ablation catheter
-
Medical University of ViennaCompleted
-
Oxford University Hospitals NHS TrustRoyal Bournemouth and Christchurch Hospitals NHS Foundation TrustCompleted
-
Sheba Medical CenterMedtronicUnknownPremature Ventricular Contraction
-
Aalborg University HospitalOdense University Hospital; St. Antonius HospitalTerminatedParoxysmal Atrial Fibrillation.Netherlands, Denmark
-
Catholic University of the Sacred HeartAbbott Medical Devices; CNR Institute of Clinical Physiology, Pisa, ItalyCompletedSupraventricular TachycardiasItaly
-
Biosense Webster, Inc.CompletedAtrial Fibrillation | Ischemic Ventricular TachycardiaCzech Republic
-
Felipe AtienzaFundación Centro Nacional de Investigaciones Cardiovasculares Carlos IIICompleted
-
The First Affiliated Hospital with Nanjing Medical...Unknown
-
Lawson Health Research InstituteUnknown
-
Charles University, Czech RepublicRecruitingAtrial FibrillationCzechia